Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,417 total articles
BlockchAIn Digital Infrastructure, Inc., a NYSE American listed company under ticker AIB, announced its first quarter 2026 financial results, showing a 9% year-over-year revenue increase to $4.9 million and a tripling of net cash provided by operating activities to $1.3 million. The company highlighted key strategic initiatives including appointmen…
Rocky Mountain Chocolate Factory, a leading franchisor of premium chocolates and confectionery, announced its upcoming participation in the LD Micro Invitational XVI Conference in Los Angeles. Interim CEO Jeff Geygan will deliver an investor presentation and meet with investors on May 18, 2026. The company operates over 250 stores across the U.S. a…
Jet.AI Inc. reported its Q1 2026 financial results, highlighting a strong cash position of $13.5 million, significant progress on its AI-driven hyperscale data center campuses, a strategic $5 million economic interest investment in SpaceX amid its rumored IPO, and an advancing merger with flyExclusive scheduled for shareholder vote in June 2026. Th…
Star Equity Holdings, Inc., a diversified holding company trading on Nasdaq under the symbols STRR and STRRP, announced a cash dividend of $0.25 per share on its 10% Series A Cumulative Perpetual Preferred Stock. The dividend's record date is June 1, 2026, with payment on June 10, 2026. The Company encompasses four divisions: Building Solutions, Bu…
RoboStrategy, Inc., a Nasdaq-listed investment fund focusing on robotics and physical AI companies, has entered into a significant committed equity facility (CEF) agreement with Roth Principal Investments, LLC. This facility allows RoboStrategy to issue and sell up to $2 billion in common stock at its discretion, expanding capital resources to fund…
HeartCore Enterprises, Inc., a Tokyo-based IPO consulting company listed on Nasdaq (HTCR), reported its financial results for Q1 2026. Despite reduced revenues and gross profit due to competitive pressures and increased outsourcing costs, the company regained compliance with Nasdaq’s minimum bid price and authorized a $2 million share repurchase. E…
DeFi Development Corp. plans to hold a live online event to recap its April 2026 operational progress, covering treasury management focused on Solana (SOL), capital markets activities, ecosystem partnerships, and updates on its AI-powered commercial real estate platform. The company's leadership will engage with investors and the community during a…
POET Technologies Inc., a designer of photonic integrated circuits for AI and data center markets, announced a registered direct offering of common shares and warrants raising $400 million. The proceeds will be used to expand manufacturing infrastructure, support corporate development including acquisitions, scale R&D, and accelerate light source b…
CorMedix Therapeutics announced that its management team will participate in investor conferences hosted by RBC Capital Markets and Jefferies in May and June 2026, where they will engage in fireside chats and investor meetings to discuss the company's developments and strategies in the biopharmaceutical sector focused on life-threatening conditions…
Data Storage Corporation announced the establishment of Sovereign AI Solutions (SaiS), a new subsidiary focused on AI continuity infrastructure for regulated industries including healthcare, financial services, and insurance. The company reported a 10.9% year-over-year increase in Nexxis sales and a 32.1% rise in gross profit, highlighting strong d…
Jyong Biotech Ltd., a Taiwan-based biotechnology company specializing in plant-derived therapeutics, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The report, which includes audited consolidated financial statements, is now accessible via the com…
Moleculin Biotech announced first quarter 2026 financial results alongside promising clinical updates for its pivotal MIRACLE Phase 3 trial evaluating Annamycin combined with cytarabine in difficult-to-treat relapsed or refractory acute myeloid leukemia (AML) patients. Early blinded data from 45 patients showed a 40% composite complete remission ra…
SRx Health Solutions announced that its board has approved a dividend distribution of 75% of profits from its investment in Astro Investment XVII, an affiliate of Astro Capital. This investment includes holdings in SpaceX and other artificial intelligence and space technology companies. The move reflects SRx Health Solutions' confidence in the long…
Bath & Body Works, Inc. has declared a regular quarterly cash dividend of $0.20 per share, payable on June 19, 2026 to shareholders of record as of June 5, 2026. The company highlights its strong brand presence in personal care and fragrance products through extensive retail and online operations.
BTCS Inc., an Ethereum-first blockchain technology company, reported Q1 2026 financial results showing a 27% year-over-year revenue increase to $2.1 million and a 745% rise in gross profit to $1.0 million with a 47% gross margin. The growth was mainly driven by the Imperium DeFi revenues, which represent nearly half of total revenue. Despite a net …
Wrap Technologies announced that William Paterson University has purchased its WrapReality virtual reality training system to enhance the university's Criminology and Criminal Justice Program. This acquisition supports immersive learning for students and aligns with Wrap's strategy to expand its VR training platform beyond traditional law enforceme…
Silexion Therapeutics Corp., a clinical-stage biotech focused on RNA interference therapies for KRAS-driven cancers, announced the exercise of warrants to raise approximately $1 million. The funds will be used as working capital to advance clinical trials, including their lead siRNA candidate SIL204 targeting locally advanced pancreatic cancer. The…
Nordic American Tankers Ltd announced several recently concluded shipping contracts with large companies, generating daily rates between $75,000 and $198,000 over various periods. Operating costs remain below $10,000 per day, which supports a robust cash position enhancing their ability to pay dividends. The contracts span from March through May, i…
Jiuzi Holdings, Inc., through its subsidiary Jiuzi New York Inc., has signed a strategic Memorandum of Understanding with a top-tier AI technology company to collaboratively develop advanced AI-driven imaging platforms, cloud infrastructure, and scalable data management solutions. This partnership aims to enhance AI analytics capabilities across va…
Obagi Medical, part of Waldencast plc (NASDAQ: WALD), disclosed encouraging interim clinical and real-world data for its new skincare innovations: the NU-GEN Cellular Renewal Serum and Saypha® MagIQ™ injectable filler, presented at the Music City Symposium for Cosmetic Advances & Laser Education (SCALE). Data from over 300 clinical sites validate t…
Safe Pro Group Inc. (NASDAQ: SPAI) announced exceptional first quarter 2026 financial results with record revenue of $1.22 million, a 560% increase from the prior year, driven by a 2,400% surge in AI-powered product sales. The company’s AI solutions, including the NODE and NODE-X edge processing systems and the SPOTD threat detection platform, demo…
INmune Bio released Phase 2 MINDFuL trial results demonstrating positive trends for XPro™ (pegipanermin) in Alzheimer's patients with inflammatory biomarkers. The findings, published in NPJ Dementia, showed consistent benefit across multiple clinical and biomarker endpoints with no amyloid-related imaging abnormalities, validating the inflammation-…
CG Oncology reported positive interim results from its Phase 2 CORE-008 Cohort CX trial evaluating the combination of cretostimogene grenadenorepvec with gemcitabine in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are BCG-exposed or BCG-unresponsive. The study showed high complete response rates, strong high-grade event-fr…
aTyr Pharma announced its Q1 2026 financial results and outlined a clear regulatory path forward for efzofitimod in pulmonary sarcoidosis. Following a Type C FDA meeting, the company plans to submit an IND in June 2026 for a global Phase 3 trial targeting patients with chronic pulmonary sarcoidosis and restrictive lung disease. Enrollment is on tra…
Cocrystal Pharma has completed enrollment in the first cohort of its Phase 1b human challenge study for CDI-988, an oral protease inhibitor targeting norovirus and coronaviruses. The company received FDA Fast Track designation for CDI-988, enabling potential accelerated development. Additionally, it secured the initial $225,000 SBIR NIH grant for i…
